Montero-Julian et al., 1998 - Google Patents
Characterization of two monoclonal antibodies against the RON tyrosine kinase receptorMontero-Julian et al., 1998
- Document ID
- 6940501475479073023
- Author
- Montero-Julian F
- Dauny I
- Flavetta S
- Ronsin C
- Andre F
- Xerri L
- Wang M
- Marvaldi J
- Breathnach R
- Brailly H
- Publication year
- Publication venue
- Hybridoma
External Links
Snippet
RON is a receptor protein tyrosine kinase belonging to the hepatocyte growth factor (HGF) receptor family. Using Récepteur d'Origine Nantais (RON) transfected cell lines, Macrophage Stimulating Protein (MSP) was identified as the ligand of RON. RON is …
- 229960000070 antineoplastic Monoclonal antibodies 0 title abstract description 22
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3053—Skin, nerves, brain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Debili et al. | The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets | |
CA2096417C (en) | Methods and compositions for cancer therapy and for prognosticating responses to cancer therapy | |
Filshie et al. | MUC18, a member of the immunoglobulin superfamily, is expressed on bone marrow fibroblasts and a subset of hematological malignancies | |
Mackay et al. | Expression and modulation of CD44 variant isoforms in humans | |
JP4276262B2 (en) | Antibodies against insulin-like growth factor I receptor and uses thereof | |
AU2008226905B2 (en) | EphA3 antibodies for the treatment of solid tumors | |
AU8383598A (en) | Agonist murine monoclonal antibody as a stimulant for megakaryocytopoiesis | |
Montero-Julian et al. | Characterization of two monoclonal antibodies against the RON tyrosine kinase receptor | |
JP7338083B2 (en) | Anti-hK2 chimeric antigen receptor (CAR) | |
US6613565B1 (en) | Use of delta-like protein to inhibit the differentiation of stem cells | |
McSweeney et al. | Canine CD34: cloning of the cDNA and evaluation of an antiserum to recombinant protein | |
CN113004406B (en) | anti-CD 47 antibodies and uses thereof | |
EP1186301B1 (en) | Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations | |
CN114656566B (en) | CD 47-targeting antibody and application thereof | |
Schmitz et al. | Evidence for integrin receptor involvement in megakaryocyte‐fibroblast interaction: A possible pathomechanism for the evolution of myelofibrosis | |
WO2023045606A1 (en) | Anti-tnfr2 monoclonal antibody and application thereof | |
Dubey et al. | Unique proliferation-associated marker expressed on activated and transformed human cells defined by monoclonal antibody | |
BROWN et al. | Demonstration by two-color flow cytometry that tyrosine kinase activity is required for down-modulation of the oncogenic neu receptor | |
Knuth et al. | Induction of tumour cell lysis by a bispecific antibody recognising epidermal growth factor receptor (EGFR) and CD3 | |
Barrande et al. | Isolation and characterization of two new monoclonal antibodies against the CD34 molecule | |
Hida et al. | Epitope analysis of cluster 1 and NK cell-related monoclonal antibodies. | |
Moore et al. | Canine CD34: cloning of the cDNA and evaluation of an antiserum to | |
IL103250A (en) | Method for prognosticating responses to cancer therapy |